To support healthcare professionals in improving adherence, a series of articles has been developped to provide digestible learning resources around the role behavior science plays in adherence, including practical insights relating to therapy areas. The articles provide a useful companion to a series of masterclasses where the subjects of adherence and behavioral science are explored in more depth.


Latest articles

A Holistic Perspective on the Menopause Transition to Improve the Patients’ Experience

Approximately 1.2 billion women worldwide will be menopausal by 2030.2  A woman’s experience with menopause is complex; it is shaped by various biological, cultural, ethical, social, psychological, situational, and behavioral factors.6  Physicians must consider these aspects during their interactions with menopausal patients to improve women’s health outcomes and quality of life.  Effective peri- and postmenopausal…

Menopause

Menopause’s impact on women’s lives and adherence to treatment during the peri- and post-menopausal period

When symptomatic, menopause can have a profound impact on multiple aspects of a woman’s life, including work3, family life, and sex life4, among others. Adherence to treatments for menopausal syndrome and other diseases during the peri- and post-menopausal period is crucial to women’s health outcomes.11-14 Menopause syndrome can impact quality of life All women experience…

Menopause

Two systems of thinking: Why do rational people make irrational choices, and how can the answer help us better understand menopause?

Behavioral science indicates that people make decisions, including medication adherence decisions, using two systems of thinking: System 1, which is rapid but intuitive and biased, and System 2, which is rational and reflective but complex. Humans tend to favor System 1 thinking. Understanding the human decision-making process allows for a better understanding of menopausal women.…

Menopause

Heuristics and decision-making: What are the effects on women going through menopause?

The human mind has evolved to make decisions and draw the most plausible conclusions regardless of the quality of the available information. The decision-making process is influenced by heuristics, or cognitive shortcuts, that can have a significant effect on adherence when relevant information is limited. Understanding heuristics can significantly help us to understand patients’ adherence…

Menopause

Activating menopause patients to improve outcomes

The Patient Activation Measure (PAM) and Medication Adherence Questionnaire (MAQ) are tools that providers can use to evaluate patients’ health behavior. The PAM can be used to evaluate patients’ ability to manage their health and conditions; the MAQ can be used to evaluate patients’ level of adherence to their prescribed therapies. Providers can use the…

Menopause

The Behavior Change Wheel: A framework for improving menopause therapy adherence

Interventions designed to improve therapy adherence are often designed without any understanding of what drives patient behavior; as a result, they are only moderately effective.  The Behavior Change Wheel (BCW) framework is a useful model for understanding and characterizing adherence behavior.  The BCW highlights the importance of addressing patients’ specific concerns regarding their menopause therapy. …

Menopause

Patient adherence: An opportunity for improving outcomes

The rapid increase in vertigo disease determinants such as ageing are transforming healthcare needs in developing countries. Medications are effective disease management solutions, but low treatment adherence is widespread. Non-adherence rates reflect a significant opportunity to improve vertigo treatment outcomes in developing countries. Physicians can use a number of simple and efficient strategies to increase…

Central Nervous System

The impact of non-adherence to therapies for vertigo: Higher costs and poorer outcomes

Medication non-adherence is widespread and annual cost estimates for developed countries total $290 billion in the US and €1.25 billion in Europe. Vertigo is a significant burden for patients and providers alike, particularly because patients tend to seek emergency care when symptoms are acute.  Small improvements in adherence could significantly improve symptom management and reduce costs. Treatment…

Central Nervous System

Patient behavior and the drivers of vertigo treatment adherence

Non-adherence factors may be organized into five categories: socioeconomic, health care team and system-related, disease-related, therapy-related, and patient-related. Behavioral drivers of non-adherence are both intentional and unintentional. Despite extensive research, no single model has yet been shown to be highly accurate in predicting patient adherence. Treatment adherence offers a significant opportunity for improved outcomes Characterizing…

Central Nervous System